Implementation of sorafenib treatment for advanced hepatocellular carcinoma: an illustration of current practice in Taiwan

BACKGROUND: Sorafenib is the first regimen listed in the treatment algorithm for hepatocellular carcinoma (HCC) worldwide. This study aimed to assess the efficacy of sorafenib treatment for advanced HCC in a clinical practice using a nationwide population study. METHODS: All patients registered with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Kun-Ming, Wu, Tsung-Han, Cheng, Chih-Hsien, Lee, Chen-Fang, Wu, Ting-Jung, Chou, Hong-Shiue, Lee, Wei-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349081/
https://www.ncbi.nlm.nih.gov/pubmed/30774429
http://dx.doi.org/10.2147/CMAR.S186678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349081/
https://www.ncbi.nlm.nih.gov/pubmed/30774429
http://dx.doi.org/10.2147/CMAR.S186678

Ejemplares similares